Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000212.3:c.1784_1802delinsGTCACA

CA915940255

Gene: ITGB3 (HGNC:3690)

Condition: Glanzmann thrombasthenia (MONDO:0100326)

Inheritance Mode: Autosomal recessive inheritance

UUID: 66d12cfa-7b48-4f33-8217-e25f30d77f68

Approved on: 2021-11-04

Published on: 2021-12-23

HGVS expressions

NM_000212.3:c.1784_1802delinsGTCACA

NC_000017.11:g.47299401_47299419delinsGTCACA

CM000679.2:g.47299401_47299419delinsGTCACA

NC_000017.10:g.45376767_45376785delinsGTCACA

CM000679.1:g.45376767_45376785delinsGTCACA

NC_000017.9:g.42731766_42731784delinsGTCACA

NG_008332.2:g.50560_50578delinsGTCACA

ENST00000559488.7:c.1784_1802delinsGTCACA

ENST00000559488.5:c.1784_1802delinsGTCACA

ENST00000560629.1:n.1749_1767delinsGTCACA

NM_000212.2:c.1784_1802delinsGTCACA

Pathogenic

PM3_Supporting PP4_Strong PM2_Supporting PVS1

Evidence Links 0

Expert Panel

Platelet Disorders VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Platelet Disorders VCEP

The NM_000212.3(ITGB3):c.1784_1802delinsGTCACA variant results in a frameshift (p.Ser595CysfsTer70) with a premature stop codon in exon 12/15 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). At least one proband has been reported with this variant, GT41 of PMID: 29675921 who meets the criteria for PP4_strong. GT41 is comopund heterozygous for this variant and Trp579Ter (classified Pathogenic by the PD-VCEP (PM3_supporting). This variant is absent from gnomAD v2.1.1 (PM2_supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PVS1, PM2_supporting, PM3_supporting, PP4_strong. (VCEP specifications version 2; date of approval 11/04/2021)

PM3_Supporting

GT41 of PMID: 29675921 is compound heterozygous for c.1784_1802delinsGTCACA and Trp579Ter (classified Pathogenic by the PD-VCEP). Confirmation of trans phase was not reported. 0.5pt

PP4_Strong

GT41 of PMID: 29675921 meets the criteria for PP4_strong; including mucocutaneous bleeding, impaired aggregation with all agonists except ristocetin, and reduced surface expression of αIIbβ3 measured by flow cytometry. ITGA2B and ITGB3 were sequenced across all exons and intron/exon boundaries.

PM2_Supporting

This variant is absent from gnomAD v2.1.1 (PM2_Supporting).

PVS1

The c.1784_1802delinsGTCACA variant results in a frameshift (p.Ser595CysfsTer70) with a premature stop codon in exon 12/15 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.